Antibiotic prophylaxis in elective thoracic surgery: Cefuroxime versus cefepime

Thoracic and Cardiovascular Surgeon

Volumn 51, Issue 2, 2003, Pages 84-88

  Turna, Akif ^a,c   Kutlu, C A ^a   Ozalp, T ^a   Karamustafaoglu, A ^a   Mulazimoglu L ^b   Bedirhan, M A ^a  

^a Yedikule Teaching Hospital   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Antibiotic prophylaxis; Cefepime; Cefuroxime; Infection; Thoracic surgery

Indexed keywords

CEFEPIME; CEFUROXIME;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BRONCHOPNEUMONIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EMPYEMA; HUMAN; INFECTION RATE; LUNG INFILTRATE; LUNG RESECTION; MAJOR CLINICAL STUDY; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORAX SURGERY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BLOOD SEDIMENTATION; BODY TEMPERATURE; BRONCHOPNEUMONIA; CEFUROXIME; CEPHALOSPORINS; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DISEASE SUSCEPTIBILITY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RANDOM ALLOCATION; SURGICAL PROCEDURES, ELECTIVE; SURGICAL WOUND INFECTION; THORACIC SURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 0038782933     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38991     Document Type: Article

References (19)

1. Fry WA. Thoracic Incisions. In T.W.Shields, ed. General Thoracic Surgery. Philadelphia: Williams and Wilkins, 1994: 381-391
2. Bernard A, Pillet M, Goudet P, Viard H. Antibiotic prophylaxis in pulmonary surgery. J Thorac Cardiovasc Surg 1994; 107: 896-900
3. Aznar R, Mateu M, Miro JM, Gatell JM, Gimferrer JM, Aznar E, et al. Antibiotic prophylaxis in non-cardiac thoracic surgery: Cefazolin versus placebo. Eur J Cardiotorac Surg 1991; 5 (10): 515-518
4. Weber DJ, Raasch R, Rutala WA. Nosocomial Infections in the ICU. The growing importance of antibiotic-resistant pathogens. Chest 1999; 115: 34S-41S
5. Cameron JL, Imbembo A, Kieffer RF, Spray S, Baker RR. Prospective clinical trial of antibiotics for pulmonary resection. Surg Gynecol Obstet 1981; 152: 156-158
6. Ferdinand B, Shennib H. Postoperative pneumonia. Chest Surg Clin N Am 1998; 8: 529-539
7. Souney PF, Stoukides CA. Infectious Disease. In Shargel L, ed. Pharmacy Review. Pennsylvania: Harwal Publishing, 1989: 449-473
8. Bruce DL, Wingard DN. Anaesthesia and the immune response. Anesthesiology 1971; 34: 271-273
9. Park SK, Brody JI, Wallace H. Immunosuppressive effect of surgery. Lancet 1971; 1: 53-55
10. Powers JH, Scheld WM. Cefepime: A new beta-lactamase-resistant broad spectrum cephalosporin. Resident & Staff Physician 1996; 6: 46-52
11. Sanders CC. Cefepime: The next generation. Clin Inf Dis 1993; 17: 369-379
12. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Crit Care Med 1994; 149: 818-824
13. Anonymous. CDC definitions for nosocomial infections, 1988. Am Rev Respir Dis 2001; 139: 1058-1059
14. Gunseren F, Mamikoglu L, Ozturk S, Yucesoy M, Biberoglu K, Yulug N, et al. A surveillance of antimicrobial resistance of Gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey. J Antimicrob Chemother 1999; 43: 373-378
15. Slack MP. Antimicrobial Chemotherapy. In. Weatheral DJ, Ledingham JGG, Warrel DA, eds., Oxford Textbook of Medicine. Oxford: Oxford University Press, 1988: 5.35-5.53
16. Truesdale R, D'Alessandri R, Manuel V, Daicoff G, Kluge RM. Antimicrobial vs placebo prophylaxis in noncardiac thoracic surgery. JAMA 1979; 241: 1254-1256
17. Spain DA. Pneumonia in the surgical patient: Duration of therapy and does organism matter? Am J Surg 2000; 179: 36S-40S
18. Walker WS, Faichney A, Raychaudhury T. Wound prophylaxis in thoracic surgery: new approach. Thorax 1984; 39: 121-124
19. Cunha BA, Gill MV. Cefepime. Med Clin North Am 1995; 79: 721-732